| Health / Medical Topics |
Pyruvate Kinase Inhibitor TLN-232
A synthetic cyclic heptapeptide with potential antineoplastic activity. Pyruvate kinase (PK) inhibitor TLN-232 targets pyruvate kinase M2 (M2PK), which may disrupt tumor cell anaerobic glycolysis. M2PK is a dimeric isoform of PK and the predominant PK isoform found in tumor cells (NCI Thesaurus)
YOU MAY ALSO LIKE
An inherited metabolic disorder characterized by the deficiency of the erythrocyte enzyme pyruvate kinase. It results in the development of hemolytic…
A genetic disorder caused by mutations in the genes that are responsible for production of protein components of the pyruvate dehydrogenase…
A rare autosomal recessive inherited metabolic disorder caused by mutations in the PC gene. It results in the accumulation of lactic acid…
A pyrrole antifungal agent isolated from several Pseudomonas species. Pyrrolnitrin interrupts the terminal electron transport system and inhibits cellular respiration. This agent…
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called histone deacetylase…
An orally bioavailable, dual kinase inhibitor of the epidermal growth factor receptor (EGFR or HER-1) and the human epidermal growth factor receptor…
